A new personalised vaccine given in combination with an immunotherapy drug has stopped skin cancer returning in patients during a trial.
This could be a major moment in cancer treatment. But how did it work - and what could it mean for future patients?
In this video...
01:11 What is melanoma and who took part in this trial?
02:01 Trial results
03:26 Personalised vaccines
04:21 How are personalised vaccines made?
05:00 Production challenges of personalised vaccines
05:57 Moderna and Merck share surge
06:29 When could patients get this vaccine?
Subscribe to our channel here:
For the latest news download the BBC News app or visit BBC.com/news
#BBCNews
|
Mark Newton, head of technical strategy ...
Philip Luck, Fmr. State Dept. deputy chi...
California Attorney General Rob Bonta to...
Six years after stepping back as working...
Subscribe to our channel here: For the...
Esther George, Former Kansas City Fed pr...
US president Donald Trump has said he wi...
For better or worse, Amazon Alexa and Go...
CNBC Business News Update with Jessica E...
President Donald Trump and the First Lad...
A new personalised vaccine given in comb...
Subscribe to our channel here: For the...
Investors want founders who understand t...
Investors want founders who understand t...